A key output of the meeting is a set of draft advocacy messages to promote misoprostol’s role in PPH prevention and treatment with a range of audiences at the global, regional, and country levels. These messages will provide a framework for driving policy change and expanding access to misoprostol in the coming years.
Please read Shafia Rashid's blog post about the meeting, in which she shares with a larger audience some of the major themes of our discussions.
The meeting participant list has been updated to facilitate follow-up communication.
Shafia Rashid, Senior Program Officer
srashid (at) familycareintl (dot) org
Family Care International (FCI), in collaboration with Gynuity Health Projects, convened individuals and representatives from organizations with an interest in improving access to misoprostol for prevention and treatment of postpartum hemorrhage (PPH).
The meeting brought together key actors, including advocates, programmers, and others, from the maternal and reproductive health community to discuss and develop advocacy strategies for improving access to misoprostol for prevention and treatment of postpartum bleeding. It provided an opportunity to:
1. review key advocacy and policy opportunities and challenges
2. develop evidence-based advocacy and policy strategies
3. draft a set of core messages
4. provide input on a draft advocacy communications strategy